You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
諾輝健康(06606.HK)國際研發中心在港啟用 未來5年料投入1億元
阿思達克 02-17 16:59
諾輝健康(06606.HK)宣布,旗下位於香港科技園的國際研發中心已落成並投入使用,將在港開始籌辦諾輝癌症早篩研究院,預期今年上半年正式營運。 研發中心第一期達約1萬平方呎,當中包括以國際最高標準打造的高通量二代測序基因檢測實驗室,該研發中心將招募全球生物高科技科學家和研究工作者,首批將招募20至30名科學家,未來五年預計總投入達1億元。 公司表示,基於自主研發的STAR-seq多維組學分子技術平台,以二代測序技術聚焦癌症篩查技術成果轉化和產品管線開發,未來會以香港為基地,推動海外商業化和全球同步臨床試驗。 諾輝健康董事長兼首席執行官朱葉青指,國際研發中心啟用後將以大陸及香港團隊為雙引擎,以保障產品管線研發如期推進。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account